ARCHIVES

Zaltrap Receives Positive Opinion For European Market From CHMP

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

May 21, 2004

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

High-Starch Diet May Raise Risk Of Pancreatic Cancer

October 25, 2002

Nutrition, Disease Oriented Contracts

December 4, 1981

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003